The FDA-approved drug, Kisunla, produced by Eli Lilly, can slow the brain’s decline in the early stages of the disease.
HOUSTON — There is promising news for patients in the early stages of Alzheimer’s and their families. The FDA has approved a new drug that can slow the…
[ad_2]
Source link
